Skip To Main Content
Ben Adams on Muck Rack

Ben Adams

Verified
Chichester
As seen in: Fierce Biotech, Fierce Pharma, Questex Media Group, The Telegraph, The BMJ, Europa Press, The Lancet, EIN News, MERRY JANE, Wealth of Geeks, Fierce Healthcare, La Crosse Tribune, The Top Line and
Senior editor of Fierce Pharma Marketing
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Ben

Contact Ben, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

GSK pens $110M biological datasets pact with AI biotech Relation

|
By Ben Adams Verified
| Fierce Biotech Verified
GSK is boosting its AI chops with a new deal worth up to $110 million with Relation. The British Big Pharma and AI-focused biotech will work together in a new research collaboration focused on “generating large-scale human cellular perturbation data and deploying them into models,” according to a July 30 release. Perturbation data are collections of biological measurements that track how systems respond to changes and are typically used in the early stages of drug development.
Open in Who Shared Issue with article?

Boston Scientific cuts guidance again after unveiling restructuring plan

|
By Ben Adams Verified
| Fierce Biotech Verified
Boston Scientific is cutting its financial guidance for the second quarter in a row as it gears up for a tough six months ahead. The medtech’s chairman and CEO, Michael Mahoney, said during a July 29 call with investors that the company “now expect[s] the second half to be more pressured than we originally anticipated.” Boston Scientific now expects full-year 2026 organic revenue growth of 5% to 6%, down from its previous guidance of 6.5% to 8%.
Open in Who Shared Issue with article?

Guardant Health taps Patrick Dempsey for emotional colorectal cancer awareness video

|
By Ben Adams Verified
| Fierce Biotech Verified
Colorectal cancer blood test maker Guardant Health has teamed up with “Grey’s Anatomy” star Patrick Dempsey for a new, highly emotional video. The actor, who has been working with Guardant and promoting its Shield test since March, stands in a dark room as a projector reveals that 55,000 people die from colon cancer in the U.S. each year.
Open in Who Shared Issue with article?
See all 2,538 licensed articles (2,738 Total)